Converge Technology Solutions Corp. - CTSDF

CTSDF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CTSDF	0	8.2	-24.4	-20.9	-37.3	-13.3	-71.4	221.8	217.2	217.2
S&P 500	-1.3	-1.8	1.0	5.9	10.6	30.4	25.4	88.1	187.6	33142.5

Compare CTSDF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CTSDF
name	Converge Technology Solutions Corp.
price	2.53
changes percentage	0
change	0
day low	2.53
day high	2.60
year high	4.44
year low	2.09
market cap	488843112
price avg 50	3.00
price avg 200	3.44
exchange	PNK
volume	800
avg volume	25131
open	2.60
previous close	None
eps	-0.57
pe	-4.44
earnings announcement	2025-03-04T13:00:00.000+0000
shares outstanding	193066000
timestamp	2024-11-15 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 42.7%

Overall Quarterly Financial Health: 41.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2705207000	2164647000	24.97
gross profit	702880000	550768000	27.62
gross profit ratio	0.26	0.25	2.12
research and development expenses	0	845000	-100.00
operating expenses	544810000	496808000	9.66
interest income	0	17490000	-100.00
interest expense	41225000	19860000	107.58
ebitda	146701000	118711000	23.58
ebitdaratio	0.05	0.07	-22.29
operating income	-62388000	70993000	-187.88
operating income ratio	-0.02	0.03	-170.32
net income	-1448000	27283000	-105.31
net income ratio	-0.0	0.01	-104.25
eps	-0.01	0.13	-107.69

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,705 million in 2023 from 2,165 million in 2022 representing a change of 24.97%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 703 million in 2023 from 551 million in 2022 representing a change of 27.62%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 147 million in 2023 from 119 million in 2022 representing a change of 23.58%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 1 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 545 million in 2023 from 497 million in 2022 representing a change of 9.66%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to -62 million in 2023 from 71 million in 2022 representing a change of -187.88%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -1 million in 2023 from 27 million in 2022 representing a change of -105.31%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.01 in 2023 from -0.01 in 2022 representing a change of -107.69%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	651847000	628766000	3.67
gross profit	154076000	151059000	2.00
gross profit ratio	0.24	0.24	-1.61
research and development expenses	0	0	NaN
operating expenses	137083000	136665000	0.31
interest income	0	0	NaN
interest expense	7328000	8427000	-13.04
ebitda	43966000	41438000	6.10
ebitdaratio	0.07	0.07	2.34
operating income	16993000	14394000	18.06
operating income ratio	0.03	0.02	13.88
net income	-163318000	-1912000	-8,441.74
net income ratio	-0.25	-0.0	-8,139.29
eps	-0.82	-0.01	-8,623.40

Overall Score of Quarterly Income Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 652 million in 2024Q2 from 629 million in 2024Q1 representing a change of 3.67%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 154 million in 2024Q2 from 151 million in 2024Q1 representing a change of 2.0%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 44 million in 2024Q2 from 41 million in 2024Q1 representing a change of 6.1%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 17 million in 2024Q2 from 14 million in 2024Q1 representing a change of 18.06%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 137 million in 2024Q2 from 137 million in 2024Q1 representing a change of 0.31%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to -163 million in 2024Q2 from -2 million in 2024Q1 representing a change of -8441.74%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.82 in 2024Q2 from -0.82 in 2024Q1 representing a change of -8623.4%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	2153362000	2248876000	-4.25
total liabilities	1541207001	1618066000	-4.75
total equity	612155000	630810000	-2.96
cash and cash equivalents	170419000	159890000	6.59
short term investments	-547000	0	NaN
long term investments	0	0	NaN
total current assets	1084344000	1128279000	-3.89
total non current assets	1069018000	1120597000	-4.60
total current liabilities	1038364000	1437906000	-27.79
total non current liabilities	502843000	180160000	179.11
common stock	599434000	595019000	0.74
retained earnings	-28167000	-18441000	-52.74
total debt	433287000	421728000	2.74

Overall Score of Annual Balance Sheet

0.4 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 2,153 million in 2023 from 2,249 million in 2022 representing a change of -4.25%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 612 million in 2023 from 631 million in 2022 representing a change of -2.96%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to -1 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,084 million in 2023 from 1,128 million in 2022 representing a change of -3.89%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to -28 million in 2023 from -18 million in 2022 representing a change of -52.74%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 433 million in 2023 from 422 million in 2022 representing a change of 2.74%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 1,541 million in 2023 from 1,618 million in 2022 representing a change of -4.75%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 170 million in 2023 from 160 million in 2022 representing a change of 6.59%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 1,038 million in 2023 from 1,438 million in 2022 representing a change of -27.79%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 599 in 2023 from 595 in 2022 representing a change of 0.74%. This indicates an increase in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	2064630000	2154168000	-4.16
total liabilities	1680940000	1567630000	7.23
total equity	383690000	586538000	-34.58
cash and cash equivalents	174087000	158615000	9.75
short term investments	-267000	0	NaN
long term investments	29877000	0	NaN
total current assets	1172401000	1091858000	7.38
total non current assets	892229000	1062310000	-16.01
total current liabilities	1166731000	1173220000	-0.55
total non current liabilities	514209000	394410000	30.37
common stock	574155000	575507000	-0.23
retained earnings	-219048000	-37140000	-489.79
total debt	331679000	288822000	14.84

Overall Score of Quarterly Balance Sheet

0.3 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 2,065 million in 2024Q2 from 2,154 million in 2024Q1 representing a change of -4.16%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 1,681 million in 2024Q2 from 1,568 million in 2024Q1 representing a change of 7.23%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 384 million in 2024Q2 from 587 million in 2024Q1 representing a change of -34.58%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates a decrease in short-term investment holdings.

  Common Stock: Common Stock decreased to 574 in 2024Q2 from 576 in 2024Q1 representing a change of -0.23%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to -219 million in 2024Q2 from -37 million in 2024Q1 representing a change of -489.79%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 332 million in 2024Q2 from 289 million in 2024Q1 representing a change of 14.84%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 174 million in 2024Q2 from 159 million in 2024Q1 representing a change of 9.75%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,172 million in 2024Q2 from 1,092 million in 2024Q1 representing a change of 7.38%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 1,167 million in 2024Q2 from 1,173 million in 2024Q1 representing a change of -0.55%. This indicates a lower short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	9982000	-88303000	111.30
operating cash flow	195816000	41586000	370.87
free cash flow	184988000	17644000	948.45
capital expenditure	-10828000	-23942000	54.77
depreciation and amortization	119983000	80065000	49.86
deferred income tax	-33894000	-4059000	-735.03
stock based compensation	3692000	5594000	-34.00
accounts payables	111328000	33174000	235.59
inventory	81757000	38147000	114.32
acquisitions net	0	-418147000	100.00
investments in property plant and equipment	-10828000	-23942000	54.77
net cash used for investing activites	-103926000	-463426000	77.57
debt repayment	-61260000	392114000	-115.62
common stock issued	0	0	NaN
common stock repurchased	-17388000	-40000000	56.53
dividends paid	-6156000	-1084000	-467.90
net cash used provided by financing activities	-113845000	336310000	-133.85
cash at end of period	170419000	159890000	6.59
accounts receivables	-98246000	-125838000	21.93
cash at beginning of period	165120000	248193000	-33.47

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 10 million in 2023 from -88 million in 2022 representing a change of 111.3%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 196 million in 2023 from 42 million in 2022 representing a change of 370.87%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 185 million in 2023 from 18 million in 2022 representing a change of 948.45%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 4 million in 2023 from 6 million in 2022 representing a change of -34.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -11 million in 2023 from -24 million in 2022 representing a change of 54.77%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 111 million in 2023 from 33 million in 2022 representing a change of 235.59%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -98 in 2023 from -126 million in 2022 representing a change of 21.93%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -6 million in 2023 from -1 million in 2022 representing a change of -467.9%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	46828000	104162000	-55.04
free cash flow	44825000	102304000	-56.18
capital expenditure	-2003000	-1858000	-7.80
depreciation and amortization	26973000	27044000	-0.26
deferred income tax	-7658000	3568000	-314.63
stock based compensation	1140000	772000	47.67
accounts receivables	-126009000	13883000	-1,007.65
accounts payables	151159000	68552000	120.50
inventory	3947000	-11574000	134.10
acquisitions net	0	-11029000	100.00
investments in property plant and equipment	-2003000	-1858000	-7.80
net cash used for investing activites	-22169000	-12887000	-72.03
debt repayment	36771000	-101398000	136.26
common stock issued	0	0	NaN
common stock repurchased	-44425000	-2296000	-1,834.89
dividends paid	-2969000	-2033999	-45.97
net cash used provided by financing activities	-15008000	-105728000	85.81
net change in cash	15764000	-11804000	233.55
cash at end of period	174087000	158615000	9.75
cash at beginning of period	158615000	170419000	-6.93

Overall Score of Quarterly Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 16 million in 2024Q2 from -12 million in 2024Q1 representing a change of 233.55%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -2 million in 2024Q2 from -2 million in 2024Q1 representing a change of -7.8%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -126 million in 2024Q2 from 14 million in 2024Q1 representing a change of -1007.65%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 47 million in 2024Q2 from 104 million in 2024Q1 representing a change of -55.04%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 45 million in 2024Q2 from 102 million in 2024Q1 representing a change of -56.18%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 1 million in 2024Q2 from 1 million in 2024Q1 representing a change of 47.67%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 151 million in 2024Q2 from 69 million in 2024Q1 representing a change of 120.5%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -3 million in 2024Q2 from -2 million in 2024Q1 representing a change of -45.97%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	18.68	10.16	83.92
net income per share	-0.01	0.13	-107.81
operating cash flow per share	1.35	0.2	592.99
free cash flow per share	1.28	0.08	1,443.01
cash per share	1.17	0.75	56.36
book value per share	4.23	2.96	42.82
tangible book value per share	-2.26	-1.86	-21.58
shareholders equity per share	4.05	2.82	43.81
interest debt per share	2.91	2.26	28.77
market cap	584696028.8	978268137.79	-40.23
enterprise value	847564028.8	1240106137.79	-31.65
pe ratio	-403.8	35.86	-1,226.15
price to sales ratio	0.22	0.45	-52.17
pocfratio	2.99	23.52	-87.31
pfcf ratio	3.16	55.44	-94.30
pb ratio	1.0	1.63	-38.83
ptb ratio	1.0	1.63	-38.83
ev to sales	0.31	0.57	-45.31
enterprise value over ebitda	5.78	10.45	-44.69
ev to operating cash flow	4.33	29.82	-85.49
ev to free cash flow	4.58	70.28	-93.48
earnings yield	-0.0	0.03	-108.88
free cash flow yield	0.32	0.02	1,654.18
debt to equity	0.65	0.77	-15.75
debt to assets	0.18	0.21	-14.02
net debt to ebitda	1.79	2.21	-18.76
current ratio	1.04	0.78	33.09
interest coverage	-1.51	3.57	-142.34
income quality	-135.23	1.82	-7,528.56
dividend yield	0.01	0.0	850.16
payout ratio	-4.25	0.04	-10,800.22
sales general and administrative to revenue	0.2	0.19	3.32
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.44	0.46	-4.47
capex to operating cash flow	0.06	0.58	-90.40
capex to revenue	0.0	0.01	-63.81
capex to depreciation	0.09	0.3	-69.82
stock based compensation to revenue	0.0	0.0	-47.19
graham number	0.95	2.85	-66.48
roic	-0.02	0.08	-127.34
return on tangible assets	-0.0	0.02	-105.34
graham net net	-5.21	-3.85	-35.47
working capital	45980000	-309627000	114.85
tangible asset value	-327796001	-396789000	17.39
net current asset value	-456863001	-489787000	6.72
invested capital	1061419000	806324000	31.64
average receivables	759256500	570822000	33.01
average payables	863268000	659576500	30.88
average inventory	115798000	131342000	-11.83
days sales outstanding	104.33	125.66	-16.98
days payables outstanding	166.02	184.5	-10.02
days of inventory on hand	13.34	35.83	-62.78
receivables turnover	3.5	2.9	20.45
payables turnover	2.2	1.98	11.13
inventory turnover	27.37	10.19	168.65
roe	-0.0	0.05	-105.43
capex per share	0.07	0.11	-33.44

• Negative

  ROE: Return on Equity (ROE) decreased to -0.00 on 2023-12-31 from 0.05 on 2022-12-31, representing a change of -105.43%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -403.80 on 2023-12-31 from 35.86 on 2022-12-31, representing a change of -1226.15%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.04 on 2023-12-31 from 0.78 on 2022-12-31, representing a change of 33.09%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.65 on 2023-12-31 from 0.77 on 2022-12-31, representing a change of -15.75%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
CTSDF
calendar year	2024	2024	NaN
revenue per share	3.27	3.09	5.78
net income per share	-0.82	-0.01	-8,615.70
operating cash flow per share	0.23	0.51	-54.13
free cash flow per share	0.22	0.5	-55.29
cash per share	0.87	0.78	11.82
book value per share	1.92	2.88	-33.25
tangible book value per share	-1.47	-1.71	13.59
shareholders equity per share	1.92	2.76	-30.36
interest debt per share	1.7	1.47	15.73
market cap	851763750.48	1147051713.69	-25.74
enterprise value	1009355750.48	1277258713.69	-20.97
pe ratio	-1.3	-149.98	99.13
price to sales ratio	1.31	1.82	-28.37
pocfratio	18.19	11.01	65.17
pfcf ratio	19.0	11.21	69.48
pb ratio	2.22	2.04	8.81
ptb ratio	2.22	2.04	8.81
ev to sales	1.55	2.03	-23.77
enterprise value over ebitda	22.96	30.82	-25.52
ev to operating cash flow	21.55	12.26	75.78
ev to free cash flow	22.52	12.48	80.36
earnings yield	-0.19	-0.0	-11,402.97
free cash flow yield	0.05	0.09	-40.99
debt to equity	0.86	0.52	67.31
debt to assets	0.16	0.13	19.14
net debt to ebitda	3.58	3.14	14.07
current ratio	1.0	0.93	7.97
interest coverage	2.32	1.71	35.76
income quality	-0.29	-54.48	99.47
dividend yield	0.0	0.0	96.57
payout ratio	-0.02	-1.06	98.29
sales general and administrative to revenue	0.21	0.22	-3.25
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.33	0.43	-24.27
capex to operating cash flow	0.04	0.02	139.79
capex to revenue	0.0	0.0	3.99
capex to depreciation	0.07	0.07	8.09
stock based compensation to revenue	0.0	0.0	42.44
graham number	5.95	0.76	679.06
roic	0.02	-2.13	101.06
return on tangible assets	-0.12	-0.0	-7,415.54
graham net net	-4.03	-3.68	-9.30
working capital	5670000	-81362000	106.97
tangible asset value	-294433000	-347697000	15.32
net current asset value	-508539000	-475772000	-6.89
invested capital	752673000	929713000	-19.04
average receivables	851484500	796922000	6.85
average payables	1026603000	949887000	8.08
average inventory	84357500	79608500	5.97
days sales outstanding	121.83	117.46	3.72
days payables outstanding	190.73	188.08	1.41
days of inventory on hand	14.95	16.21	-7.81
receivables turnover	0.74	0.77	-3.59
payables turnover	0.47	0.48	-1.39
inventory turnover	6.02	5.55	8.47
roe	-0.43	-0.0	-12,415.98
capex per share	0.01	0.01	10.00

• Negative

  ROE: Return on Equity (ROE) decreased to -0.43 on 2024-06-30 Q2 from -0.00 on 2024-03-31 Q1, representing a change of -12415.98%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -1.30 on 2024-06-30 Q2 from -149.98 on 2024-03-31 Q1, representing a change of 99.13%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.00 on 2024-06-30 Q2 from 0.93 on 2024-03-31 Q1, representing a change of 7.97%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.86 on 2024-06-30 Q2 from 0.52 on 2024-03-31 Q1, representing a change of 67.31%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None